Pros and cons for statins use and risk of Parkinson's disease: An updated perspective

Parkinson's disease (PD) is the second most frequent neurodegenerative brain disease (NBD) after Alzheimer's disease (AD). Statins are the most common lipid‐lowering agents used in the management of dyslipidemia and the prevention of primary and secondary cardiovascular diseases (CVD) even...

Descripción completa

Detalles Bibliográficos
Autores principales: Al‐kuraishy, Hayder M., Al‐Gareeb, Ali I., Alexiou, Athanasios, Papadakis, Marios, Alsayegh, Abdulrahman A., Almohmadi, Najlaa Hamed, Saad, Hebatallah M., Batiha, Gaber El‐Saber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944858/
https://www.ncbi.nlm.nih.gov/pubmed/36811160
http://dx.doi.org/10.1002/prp2.1063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944858/
https://www.ncbi.nlm.nih.gov/pubmed/36811160
http://dx.doi.org/10.1002/prp2.1063

Ejemplares similares